The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Progress and prospects: immune responses to viral vectors
Open accessAbstract
Viral vectors are potent gene delivery platforms used for the treatment of genetic and acquired diseases. However, just as viruses have evolved to infect cells efficiently, the immune system has evolved to fight off what it perceives as invading pathogens. Therefore, innate immunity and antigen-specific adaptive immune responses against vector-derived antigens reduce the efficacy and stability of in vivo gene transfer. In addition, a number of vectors are derived from parent viruses that humans encounter through natural infection, resulting in preexisting antibodies and possibly in memory responses against vector antigens. Similarly, antibody and T-cell responses may be directed against therapeutic gene products that often differ from the endogenous nonfunctional or absent protein that is being replaced. As details and mechanisms of such immune reactions are uncovered, novel strategies are being developed, and vectors are being specifically engineered to avoid, suppress or manipulate the response, ideally resulting in sustained expression and immune tolerance to the transgene product. This review provides a summary of our current knowledge of the interactions between the immune system adeno-associated virus, adenoviral and lentiviral vectors, and their transgene products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
Muruve, D. A., Pétrilli, V., Zaiss, A. K., White, L. R., Clark, S. A., Ross, P. J., Parks, R. J., & Tschopp, J. (2008) · Nature · doi:10.1038/nature06664 · Cited by 936
Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses
Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J., & Wilson, J. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/595830 · Cited by 808
Cd8(+) T-Cell Responses to Adeno-Associated Virus Capsid in Humans
Mingozzi, F., Maus, M. V., Hui, D. J., Sabatino, D. E., Murphy, S. L., Rasko, J. E. J., Ragni, M. V., Manno, C. S., Sommer, J., Jiang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1549 · Cited by 748
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
Zhu, J., Huang, X., & Yang, Y. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37607 · Cited by 330
Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., Rouhani, F., Conlon, T. J., Calcedo, R., Betts, M. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904514106 · Cited by 327
Mingozzi, F., Meulenberg, J. J., Hui, D. J., Basner-Tschakarjan, E., Hasbrouck, N. C., Edmonson, S. A., Hutnick, N. A., Betts, M. R., Kastelein, J. J., Stroes, E. S., et al. (2009) · Blood · doi:10.1182/blood-2008-07-167510 · Cited by 295
New Insights on Adenovirus as Vaccine Vectors
Lasaro, M. O., & Ertl, H. C. (2009) · Molecular Therapy · doi:10.1038/mt.2009.130 · Cited by 263
Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice
Brown, B. D., Cantore, A., Annoni, A., Sergi, L. S., Lombardo, A., Della Valle, P., D'Angelo, A., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2007-03-078493 · Cited by 252
Breous, E., Somanathan, S., Vandenberghe, L. H., & Wilson, J. M. (2009) · Hepatology · doi:10.1002/hep.23043 · Cited by 237
Zhong, L., Li, B., Jayandharan, G., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Herzog, R. W., Weigel-Van Aken, K. A., Hobbs, J. A., Zolotukhin, S., et al. (2008) · Virology · doi:10.1016/j.virol.2008.08.027 · Cited by 232
Self-citationCao, O., Dobrzynski, E., Wang, L., Nayak, S., Mingle, B., Terhorst, C., & Herzog, R. W. (2007) · Blood · doi:10.1182/blood-2007-02-073304 · Cited by 220
Self-citationOthman, M., Labelle, A., Mazzetti, I., Elbatarny, H. S., & Lillicrap, D. (2007) · Blood · doi:10.1182/blood-2006-06-032524 · Cited by 220
Wang, Z., Kuhr, C. S., Allen, J. M., Blankinship, M., Gregorevic, P., Chamberlain, J. S., Tapscott, S. J., & Storb, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300161 · Cited by 218
Mastrangeli, A., Harvey, B.-G., Yao, J., Wolff, G., Kovesdi, I., Crystal, R. G., & Falck-Pedersen, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-79 · Cited by 204
Appledorn, D. M., Patial, S., McBride, A., Godbehere, S., Van Rooijen, N., Parameswaran, N., & Amalfitano, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2134 · Cited by 198
Pien, G. C., Basner-Tschakarjan, E., Hui, D. J., Mentlik, A. N., Finn, J. D., Hasbrouck, N. C., Zhou, S., Murphy, S. L., Maus, M. V., Mingozzi, F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36891 · Cited by 192
Brown, B. D., Sitia, G., Annoni, A., Hauben, E., Sergi, L. S., Zingale, A., Roncarolo, M. G., Guidotti, L. G., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2006-10-049312 · Cited by 188
McCoy, K., Tatsis, N., Korioth-Schmitz, B., Lasaro, M. O., Hensley, S. E., Lin, S.-W., Li, Y., Giles-Davis, W., Cun, A., Zhou, D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02497-06 · Cited by 185
(2008) · PubMed Central · Cited by 183
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
Zaiss, A. K., & Muruve, D. A. (2008) · Gene Therapy · doi:10.1038/gt.2008.54 · Cited by 180
Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors
Zaiss, A. K., Cotter, M. J., White, L. R., Clark, S. A., Wong, N. C. W., Holers, V. M., Bartlett, J. S., & Muruve, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.01990-07 · Cited by 177
Lowenstein, P. R., Mandel, R. J., Xiong, W.-D., Kroeger, K. M., & Castro, M. G. (2007) · Current Gene Therapy · doi:10.2174/156652307782151498 · Cited by 167
Nociari, M., Ocheretina, O., Schoggins, J. W., & Falck-Pedersen, E. (2007) · Journal of Virology · doi:10.1128/jvi.02685-06 · Cited by 159
Annoni, A., Brown, B. D., Cantore, A., Sergi, L. S., Naldini, L., & Roncarolo, M. (2009) · Blood · doi:10.1182/blood-2009-04-214569 · Cited by 142
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
O’Brien, K. L., Liu, J., King, S. L., Sun, Y.-H., Schmitz, J. E., Lifton, M. A., Hutnick, N. A., Betts, M. R., Dubey, S. A., Goudsmit, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1991 · Cited by 142
Hepatic Gene Transfer as a Means of Tolerance Induction to Transgene Products
LoDuca, P. A., Hoffman, B. E., & Herzog, R. W. (2009) · Current Gene Therapy · doi:10.2174/156652309787909490 · Cited by 122
Self-citationPichlmair, A., Diebold, S. S., Gschmeissner, S., Takeuchi, Y., Ikeda, Y., Collins, M. K., & Sousa, C. R. E. (2006) · Journal of Virology · doi:10.1128/jvi.01818-06 · Cited by 114
Wang, L., Figueredo, J., Calcedo, R., Lin, J., & Wilson, J. M. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.001 · Cited by 113
Pre-existing AAV Capsid-specific CD8+ T Cells are Unable to Eliminate AAV-transduced Hepatocytes
Li, H., Murphy, S. L., Giles‐Davis, W., Edmonson, S. A., Xiang, Z., Li, Y., Lasaro, M. O., High, K. A., & Ertl, H. C. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300090 · Cited by 112
McCaffrey, A. P., Fawcett, P., Nakai, H., McCaffrey, R. L., Ehrhardt, A., Pham, T.-T. T., Pandey, K., Xu, H., Feuss, S., Storm, T. A., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.37 · Cited by 112
Yuasa, K., Yoshimura, M., Urasawa, N., Ohshima, S., Howell, J. M., Nakamura, A., Hijikata, T., Miyagoe‐Suzuki, Y., & Takeda, S. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302984 · Cited by 111
Sinn, P. L., Burnight, E. R., Hickey, M. A., Blissard, G. W., & McCray, P. B. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12818-12827.2005 · Cited by 110
Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P. L., Nam, H.-J., Agbandje‐McKenna, M., & Wilson, J. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803965 · Cited by 109
Evading the immune response upon in vivo gene therapy with viral vectors.
Sack, B. K., & Herzog, R. W. (2009) · PubMed · Cited by 106
Self-citationDiverse IgG subclass responses to adeno‐associated virus infection and vector administration
Murphy, S. L., Li, H., Mingozzi, F., Sabatino, D. E., Hui, D. J., Edmonson, S. A., & High, K. A. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21360 · Cited by 101
Hutnick, N. A., Carnathan, D. G., Dubey, S. A., Makedonas, G., Cox, K. S., Kierstead, L. S., Ratcliffe, S. J., Robertson, M. N., Casimiro, D. R., Ertl, H. C. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1989 · Cited by 100
Role of MyD88 and TLR9 in the Innate Immune Response Elicited by Serotype 5 Adenoviral Vectors
Yamaguchi, T., Kawabata, K., Koizumi, N., Sakurai, F., Kaneda‐Nakashima, K., Sakurai, H., Sasaki, T., Okada, N., Yamanishi, K., & Mizuguchi, H. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.016 · Cited by 98
Seregin, S. S., Appledorn, D. M., McBride, A. J., Schuldt, N. J., Aldhamen, Y. A., Voss, T. T., Wei, J.-P., Bujold, M., Nance, W., Godbehere, S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.297 · Cited by 97
Innate Immune Recognition of Viruses and Viral Vectors
Huang, X., & Yang, Y. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.141 · Cited by 96
Zhu, J., Huang, X., & Yang, Y. (2008) · Molecular Therapy · doi:10.1038/mt.2008.88 · Cited by 90
Li, C., Hirsch, M. L., Asokan, A., Zeithaml, B., Ma, H., Kafri, T., & Samulski, R. J. (2007) · Journal of Virology · doi:10.1128/jvi.00529-07 · Cited by 89
Stieger, K., Schroeder, J., Provost, N., Mendes-Madeira, A., Belbellaa, B., Meur, G. L., Weber, M., Deschamps, J.-Y., Lorenz, B., Moullier, P., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.283 · Cited by 88
Lin, S.-W., Hensley, S. E., Tatsis, N., Lasaro, M. O., & Ertl, H. C. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33138 · Cited by 88
Immune Responses to Lentiviral Vectors
Follenzi, A., Santambrogio, L., & Annoni, A. (2007) · Current Gene Therapy · doi:10.2174/156652307782151515 · Cited by 87
Brunetti‐Pierri, N., Stapleton, G. E., Palmer, D. J., Zuo, Y., Mane, V. P., Finegold, M. J., Beaudet, A. L., Leland, M. M., Mullins, C. E., & Ng, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300102 · Cited by 78
Brown, M., Bellon, M., & Nicot, C. (2006) · Blood · doi:10.1182/blood-2006-04-015537 · Cited by 78
A New Genetic Vaccine Platform Based on an Adeno-Associated Virus Isolated from a Rhesus Macaque
Lin, J., Calcedo, R., Vandenberghe, L. H., Bell, P. L., Somanathan, S., & Wilson, J. M. (2009) · Journal of Virology · doi:10.1128/jvi.01441-09 · Cited by 72
Immune Response to Helper Dependent Adenoviral Mediated Liver Gene Therapy: Challenges and Prospects
Seiler, M. P., Cerullo, V., & Lee, B. (2007) · Current Gene Therapy · doi:10.2174/156652307782151452 · Cited by 72
Appledorn, D., McBride, A. J., Seregin, S. S., Scott, J. M., Schuldt, N. J., Kiang, A., Godbehere, S., & Amalfitano, A. (2008) · Gene Therapy · doi:10.1038/gt.2008.114 · Cited by 69
Passini, M. A., Bu, J., Fidler, J. A., Ziegler, R. J., Foley, J. W., Dodge, J. C., Yang, W. W., Clarke, J. L., Taksir, T. V., Griffiths, D. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703509104 · Cited by 67
Vandenberghe, L. H., & Wilson, J. M. (2007) · Current Gene Therapy · doi:10.2174/156652307782151416 · Cited by 67
Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+T-Cell Responses in Mice
Lin, J., Zhi, Y., Mays, L., & Wilson, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.01253-07 · Cited by 66
NAYAK, S., CAO, O., HOFFMAN, B. E., COOPER, M., ZHOU, S., ATKINSON, M. A., & HERZOG, R. W. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03548.x · Cited by 66
Self-citationKremer, K. L., Dunning, K. R., Parsons, D., & Anson, D. S. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1025 · Cited by 65
Zhu, J., Huang, X., & Yang, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3505 · Cited by 57
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
Peruzzi, D., Dharmapuri, S., Cirillo, A., Bruni, B. E., Nicosia, A., Cortese, R., Colloca, S., Ciliberto, G., Monica, N. L., & Aurisicchio, L. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.051 · Cited by 54
Martino, A. T., Nayak, S., Hoffman, B. E., Cooper, M., Liao, G., Markusic, D. M., Byrne, B. J., Terhorst, C., & Herzog, R. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006376 · Cited by 54
Self-citationHauswirth, W. W., Alemán, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.107 · Cited by 47
Velazquez, V. M., Bowen, D. G., & Walker, C. M. (2009) · Blood · doi:10.1182/blood-2008-01-131375 · Cited by 46
Muscle as a Target for Supplementary Factor IX Gene Transfer
Hoffman, B. E., Dobrzynski, E., Wang, L., Hirao, L. A., Mingozzi, F., Cao, O., & Herzog, R. W. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.042 · Cited by 45
Self-citationPeden, C. S., Manfredsson, F. P., Reimsnider, S. K., Poirier, A. E., Burger, C., Muzyczka, N., & Mandel, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.284 · Cited by 44
Siders, W., Shields, J., Kaplan, J. M., Lukason, M., Woodworth, L. A., Wadsworth, S., & Scaria, A. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.055 · Cited by 23
Markusic, D. M., van Til, N. P., Hiralall, J. K., Elferink, R. P. J. O., & Seppen, J. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-85 · Cited by 13
Herzog, R. W. (2012) · Cited by 10
Self-citationSiders, W., Shields, J. D., Kaplan, J. M., Lukason, M., Woodworth, L. A., Wadsworth, S. C., & Scaria, A. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.055 · Cited by 3
Cited by
Delivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,739
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Tools for translation: non-viral materials for therapeutic mRNA delivery
Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799
Metadata
- Authors
- Nayak, S., & Herzog, R. W.
- Venue
- Gene Therapy
- Published
- 2009-11-12
- Volume
- 17
- Issue
- 3
- Pages
- 295-304
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W1985040895
- Cited by
- 634
- References
- 70
- FWCI
- 20.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.